Patrizia Cavazzoni was the head of the FDA’s Center for Drug Evaluation and Research, from 2020 until her departure in January. FDA. By Matthew Herper. Feb. 24, 2025.

The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency. The seven-year FDA veteran communicated the decision in ...

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.

Pfizer (NYSE:PFE) has tapped Patrizia Cavazzoni, the former head of drug regulation at the FDA, as its new chief medical officer. Cavazzoni was most recently director of the Center for Drug ...

Patrizia Cavazzoni, MD, has been chosen as the permanent director of the Center for Drug Evaluation and Research at the FDA, the agency's acting commissioner, Janet Woodcock, MD, tweeted April 12.

"It is the FDA's role to ensure that drugs are safe and effective," said Dr. Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, in a news release on Thursday.

The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald ...

The FDA cleared Opill to ... daily oral contraceptive will be an available option for millions of people in the United States,” said Patrizia Cavazzoni, director of the FDA’s Center for ...

WebMD's Chief Medical Officer, John Whyte, MD, speaks with Patrizia Cavazzoni, MD, Director, Center for Drug Evaluation and Research (CDER), FDA, about the impact of COVID-19 on the FDA's ...

"It is the FDA’s role to ensure that drugs are safe and effective," Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.